A phase I study of bortezomib and temozolomide in patients with advanced solid tumors

被引：0
|
作者：
J. Portnow
P. Frankel
S. Koehler
P. Twardowski
S. Shibata
C. Martel
R. Morgan
M. Cristea
W. Chow
D. Lim
V. Chung
K. Reckamp
L. Leong
T. W. Synold
机构：
[1] City of Hope,Department of Medical Oncology
来源：
Cancer Chemotherapy and Pharmacology | 2012年 / 69卷
关键词：
Bortezomib; Temozolomide; Phase I; Pharmacokinetics; Hepatic enzyme-inducing anticonvulsants;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：505 / 514
页数：9
相关论文
共 50 条
  • [31] A phase I study of resminostat in Japanese patients with advanced solid tumors
    Satoru Kitazono
    Yutaka Fujiwara
    Shinji Nakamichi
    Hidenori Mizugaki
    Hiroshi Nokihara
    Noboru Yamamoto
    Yasuhide Yamada
    Eri Inukai
    Osamu Nakamura
    Tomohide Tamura
    Cancer Chemotherapy and Pharmacology, 2015, 75 : 1155 - 1161
  • [32] Phase I study of olaratumab in Japanese patients with advanced solid tumors
    Doi, Toshihiko
    Ma, Yan
    Dontabhaktuni, Aruna
    Nippgen, Cornelia
    Nippgen, Johannes
    Ohtsu, Atsushi
    CANCER SCIENCE, 2014, 105 (07) : 862 - 869
  • [33] A phase I study of the ceramide nanoliposome in patients with advanced solid tumors
    Aaron Ciner
    Theodore Gourdin
    Jeff Davidson
    Mylisa Parette
    Susan J. Walker
    Todd E. Fox
    Yixing Jiang
    Cancer Chemotherapy and Pharmacology, 2024, 93 : 23 - 29
  • [34] A phase i study of ixazomib and erlotinib in patients with advanced solid tumors
    Shumei Kato
    Jacob J. Adashek
    Vivek Subbiah
    Siqing Fu
    Mianen Sun
    Ly Nguyen
    Elsa J. Brown
    Timothy A. Yap
    Daniel D. Karp
    Sarina A. Piha-Paul
    David S. Hong
    Investigational New Drugs, 2022, 40 : 99 - 105
  • [35] Phase I study of piritrexim and gemcitabine in patients with advanced solid tumors
    Huie, M
    Carducci, M
    Liu, G
    Wilding, GG
    Marnocha, R
    Izquierda, M
    Thomas, J
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2005, 28 (06): : 613 - 617
  • [36] Phase I study on docetaxel and Gemcitabine in patients with advanced solid tumors
    Jaremtchuk, AV
    Zarba, JJ
    Ferro, A
    ANNALS OF ONCOLOGY, 1998, 9 : 138 - 139
  • [37] Phase I study of oral rigosertib in patients with advanced solid tumors
    Bowles, Daniel W.
    Diamond, Jennifer Robinson
    Lam, Elaine Tat
    Messersmith, Wells A.
    Weekes, Colin D.
    Leong, Stephen
    Gore, Lia
    Lieu, Christopher Hanyoung
    Freas, Elizabeth
    Ren, Chen
    Wilhelm, Francois
    Eckhardt, S. Gail
    Jimeno, Antonio
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [38] A phase I study of oral ixabepilone in patients with advanced solid tumors
    John F. Deeken
    John L. Marshall
    Michael J. Pishvaian
    Jimmy Hwang
    Christoph M. Ahlers
    Pamela L. Clemens
    Susan M. Parker
    Lisa Iacono
    Patricia M. LoRusso
    Cancer Chemotherapy and Pharmacology, 2014, 73 : 1071 - 1078
  • [39] A phase I study of resminostat in Japanese patients with advanced solid tumors
    Kitazono, Satoru
    Fujiwara, Yutaka
    Nakamichi, Shinji
    Mizugaki, Hidenori
    Nokihara, Hiroshi
    Yamamoto, Noboru
    Yamada, Yasuhide
    Inukai, Eri
    Nakamura, Osamu
    Tamura, Tomohide
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2015, 75 (06) : 1155 - 1161
  • [40] A phase I study of vorinostat in combination with bortezomib in refractory solid tumors
    Ninan, J. A.
    Bailey, H.
    Kolesar, J.
    Marnocha, R.
    Eickhoff, J.
    Wright, J.
    Espinoza-Delgado, I.
    Alberti, D.
    Wilding, G.
    Schelman, W.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
12345